This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In recent years, artificial intelligence (AI) has been used to improve the precision of valvular heartdisease diagnosis and treatment. This review article explores the various potential applications of AI in the diagnosis and treatment of valvular heartdisease in more detail.
Adipose-derived mesenchymal stem cells (ASCs) represent an innovative candidate to treat ischemic heartdisease (IHD) due to their abundance, renewable sources, minor invasiveness to obtain, and no ethical limitations.
Background While research on congenital heartdisease has been extensively conducted worldwide, comprehensive studies from developing countries and the Arab world remain scarce. Aim This study aims to perform a bibliometric review of research on congenital heartdisease in the Arab world from 1997 to 2022.
Widely recognized for pioneering innovative concepts and techniques in TAVR, Tang has set contemporary standards in the field. His impressive international academic collaborations include the establishment of multiple global registries and the training of heart teams in structural heart imaging and procedures worldwide.
The idea that obesity increases the risk of heart failure seems like an obvious conclusion. After all, as the Framingham Heart Study clearly showed, obesity and overweight are significantly associated with a higher risk of hypertension, angina and coronary heartdisease.
Cleerly, a digital healthcare company focused on heartdisease, has announced continued strong scientific evidence supporting the clinical utility of its products, detailing a study published online on Jan. 25, 2024 in the European Heart Journal Cardiovascular Imaging. In Press European Heart Journal CV Imag 2024.This
These innovative companies leverage AI to develop cutting-edge diagnostic tools, predictive analytics, and personalized medicine approaches. These companies are at the forefront of innovation, driving improvements in patient outcomes and reshaping the future of healthcare delivery.
Advancements in medical technology have revolutionized the diagnosis and treatment of heartdiseases, which pose critical chronic conditions that, if left unattended, can have fatal consequences. These algorithms, trained on large datasets, recognize patterns and features associated with heartdiseases.
Widely recognized for pioneering innovative concepts and techniques in TAVR, Tang has set contemporary standards in the field. His impressive international academic collaborations include the establishment of multiple global registries and the training of heart teams in structural heart imaging and procedures worldwide.
A 76-year-old woman with a history of double valve replacement (Aortic and mitral valves) for rheumatic heartdisease, presented with acute dyspnea after a switch from Warfarin to LMWH before a planned bone marrow biopsy. The innovative double balloon catheter Inflation across the the mechanical prosthetic valve is possible.
Meanwhile, traditional methods for cardiac detection still rely on reactive, symptom-driven interventions that often catch heartdisease too late, when treatment is complex, critical and costly. AI-enabled remote cardiac monitoring is is already revolutionizing how we detect, diagnose, mitigate and manage heart conditions.
Ischemic heartdisease (IHD) is one of the world's foremost killers, accounting for 16% of all deaths worldwide. IHD is the main cause of heart failure (HF), as it leads to pathological changes in the heart, improper pumping function and eventual death.
February 1, 2024 — As cardiologists, heartdisease patients and the organizations that serve them across the country embark on American Heart Month, DAIC has compiled a snapshot of significant cardiovascular disease (CVD) and stroke statistics, along with a review of the atherosclerosis drug market.
And the death risk associated with heart risk makes it crucial to recognize the early signs of a heart attack and seek prompt medical attention to save a person’s life. This article delves into heart attack symptoms, golden hour, treatment & prevention. Both of them increase the chances of developing heartdisease.
Atrial cardiomyopathy is a multifaceted heartdisease characterized by structural and functional abnormalities of the atria and is closely associated with atrial fibrillation and its complications. Its etiology involves a number of factors, including genetic, infectious, immunologic, and metabolic factors.
When the Mail on Sunday published their libelous articles about me on March 3 rd , 2019, I was expecting it. But it was entirely predictable what the main thrust of any article was going to be. And if you dare to suggest the idea that low-fat foods do not protect against heartdisease, you get much the same treatment.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content